(Q33374241)

English

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Mattias Johansson

object named as

Mattias Johansson

31

0 references

Gianluca Severi

object named as

Gianluca Severi

26

0 references

16

object named as

Rudolf Kaaks

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

15

object named as

Elio Riboli

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

39

object named as

Pilar Galan

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

28

object named as

Graham G Giles

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Göran Hallmans

30

object named as

Göran Hallmans

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Edward L. Giovannucci

22

object named as

Edward Giovannucci

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

object named as

Luigi Ferrucci

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dallas R. English

27

object named as

Dallas R English

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

14

object named as

Sabina Rinaldi

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Paul N. Appleby

3

object named as

Paul Appleby

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Elizabeth A Platz

20

object named as

Elizabeth A Platz

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Charles Quesenberry

24

object named as

Charles P Quesenberry

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9

object named as

Noel S Weiss

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

29

object named as

Pär Stattin

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kathy J. Helzlsouer

13

object named as

Kathy Helzlsouer

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jenny L Donovan

36

object named as

Jenny Donovan

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H Ballentine Carter

6

object named as

H Ballentine Carter

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Annette L Fitzpatrick

10

object named as

Annette Fitzpatrick

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Andrew W Roddam

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Naomi E Allen

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Timothy J Key

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

E Jeffrey Metter

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chu Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ann W Hsing

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

James V Lacey

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Joop A M J L Janssen

17

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mark F Wildhagen

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fritz H Schröder

19

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michael Pollak

21

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Catherine Schaefer

23

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Joseph H Vogelman

25

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

June M Chan

32

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peter Gann

33

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Steven E Oliver

34

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jeff M Holly

35

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

François Meyer

37

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Isabelle Bairati

38

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Annals of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

149

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

461-71, W83-8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Human prostate cancer risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Cellular actions of the insulin-like growth factor binding proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Insulin-like growth factors and their binding proteins: biological actions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

14 July 2018

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Prostate cancer and the Will Rogers phenomenon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584869

31 October 2018

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factors and prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18838726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.7326/0003-4819-149-7-200810070-00006

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33374241&oldid=2061477328"